Skip to main content
. 2021 Jun 10;11:643654. doi: 10.3389/fonc.2021.643654

Table 2.

Treatment-Related Toxicities.

Adverse Event Grade1-2 Grade3
Hand and foot syndrome 17 (25.8%) 4 (6.1%)
Secondary hypertension 15 (22.7%) 2 (3.0%)
Fatigue 11 (16.7%) 1 (1.5%)
Pain 9 (13.6%) 0
Oral mucositis 5 (7.6%) 0
Diarrhea 3 (4.5%) 0
Liver dysfunction 2 (3.0%) 0
Nausea 2(3.0%) 0
Hemorrhage 2(3.0%) 0